Amdocs Limited's Revenue in the fiscal year 2025 $ 4,532.91 millions
Amdocs Limited's Revenue in the fiscal year 2024 $ 5,004.99 millions
Amdocs Limited's Revenue in the fiscal year 2023 $ 4,887.55 millions
Amdocs Limited's Revenue in the fiscal year 2022 $ 4,576.70 millions
Amdocs Limited's Revenue in the fiscal year 2021 $ 4,288.64 millions
DOX Revenue third quarter 2026 Y/Y Growth Comment
Amdocs Limited reported Revenue growth of 4.14% year on year in the third quarter 2026, to $ 1,174.90 millions, this is lower than Amdocs Limited's recent average Revenue growth of 6.55%.
Looking into third quarter 2026 results within Cloud Computing & Data Analytics industry 73 other companies have achieved higher Revenue growth. While Amdocs Limited' s Revenue increase of 4.14% ranks overall at the positon no. 2328 in the third quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Amdocs Limited's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
6.11 %
-1.15 %
-100 %
0
DOX's III. Quarter Q/Q Revenue Comment
Amdocs Limited achieved in the III. Quarter 2026 above company average sequential Revenue growth of 0.25%, to $ 1,174.90 millions, from $1,171.98 millions in the second quarter. DOX is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Cloud Computing & Data Analytics industry 70 other companies have achieved higher Revenue quarter on quarter growth. While Amdocs Limited's Revenue growth quarter on quarter, overall rank is 2524.
Amdocs Limited achieved in the III. Quarter 2026 above company average sequential Revenue growth of 0.25%, to $ 1,174.90 millions, from $1,171.98 millions in the second quarter. DOX is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Cloud Computing & Data Analytics industry 70 other companies have achieved higher Revenue quarter on quarter growth. While Amdocs Limited's Revenue growth quarter on quarter, overall rank is 2524.
Amdocs Limited's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Sep 30 2025)
12 Months Ending (Sep 30 2024)
12 Months Ending (Sep 30 2023)
12 Months Ending (Sep 30 2022)
12 Months Ending (Sep 30 2021)
Cumulative Revenue 12 Months Ending
$ 4,532.91
$ 5,004.99
$ 4,887.55
$ 4,576.70
$ 4,288.64
Y / Y Revenue Growth (TTM)
-9.43 %
2.4 %
6.79 %
6.72 %
2.87 %
Year on Year Revenue Growth Overall
Ranking
# 3183
#
#
#
# 2014
Seqeuential Revenue Change (TTM)
-9.43 %
2.4 %
6.79 %
6.72 %
2.87 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 3183
#
#
#
# 2014
Cumulative Revenue growth Comment
For the 12 months ended Sep 30 2025 Amdocs Limited reported a decrease in Revenue by -9.43% year on year, to $4,533 millions, compare to the 2.4% growth at Sep 30 2024.
In the Technology sector 365 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from to 3183.
For the 12 months ended Sep 30 2025 Amdocs Limited reported a decrease in Revenue by -9.43% year on year, to $4,533 millions, compare to the 2.4% growth at Sep 30 2024.
In the Technology sector 365 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from to 3183.
About Amdocs Limited Revenue Growth Rates (DOX), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.